Raymond James & Associates’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-21,362
| Closed | -$266K | – | 3826 |
|
|
2023
Q2 | $266K | Buy |
21,362
+5,229
| +32% | +$65K | ﹤0.01% | 3301 |
|
|
2023
Q1 | $226K | Buy |
+16,133
| New | +$226K | ﹤0.01% | 3393 |
|
|
2022
Q4 | – | Sell |
-14,875
| Closed | -$380K | – | 3852 |
|
|
2022
Q3 | $380K | Buy |
+14,875
| New | +$380K | ﹤0.01% | 3015 |
|
|
2021
Q4 | – | Sell |
-10,959
| Closed | -$538K | – | 4041 |
|
|
2021
Q3 | $538K | Buy |
10,959
+469
| +4% | +$23K | ﹤0.01% | 3002 |
|
|
2021
Q2 | $438K | Sell |
10,490
-60
| -0.6% | -$2.51K | ﹤0.01% | 3172 |
|
|
2021
Q1 | $376K | Buy |
+10,550
| New | +$376K | ﹤0.01% | 3192 |
|